Clinical Trials Day - Q&A with Clinicierge
The US Food and Drug Administrarion will soon require researchers and companies seeking approval for late-stage clinical trials to submit a diversity plan for trial participants. Scott Gray, CEO of Clincierge, discusses how trial sponsors and CROs can improve patient diversity, recruitment, and retention through patient support services.
Source: outsourcing-pharma.com